Download European Society of Cardiology Congress 2011 - Post-Conference Review and Analysis Brochure

Brochure
More information from http://www.researchandmarkets.com/reports/1934395/
European Society of Cardiology Congress 2011 - Post-Conference Review and
Analysis
Description:
European Society of Cardiology Congress 2011 - Post-Conference Review and Analysis
Summary
GlobalData, the industry analysis specialist, has released its new conference alerts, “European Society of
Cardiology Congress 2011 - Post-Conference Review and Analysis”. The conference alert is an essential
source of information and analysis on the emerging therapies and new disease management techniques.
Scope
The report provides complete coverage of conference. Its scope includes - Qualitative analysis of the studies and clinical trials presented at the conference and their impact on the
key market dynamics and future treatment paradigm.
- Review of pre- and post-conference KOL/analyst comments
- Market revenue data for 2010 and forecast forward to 2017 for a specific disease area (if the conference
being covered is focused on a specific disease area).
- Review of key industry trends and events which are likely to impact and change the dynamics of the
concerned disease markets in the long run.
Reasons to buy
The report will serve to facilitate your decision making in the concerned therapy areas. It will allow you to - Develop business strategies by understanding the trends and developments that are driving or are
expected to drive the market in the concerned disease areas.
- Explore M&A opportunities by identifying key products and market players.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the market opportunities.
- Make more informed business decisions from the insightful and in-depth analysis of the market and the
factors influencing the same.
Contents:
1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 European Society of Cardiology Congress 2011 - Post-Conference Highlights
2.1 ARISTOTLE - Efficacy and Safety of Apixaban Compared to Warfarin for Prevention of Stroke and
Systemic Embolism in 18,202 Patients with Atrial Fibrillation - Primary Results of the ARISTOTLE Trial
2.2 Efficacy And Safety Of The Novel Oral Factor Xa Inhibitor Apixaban In Atrial Fibrillation (Af) Patients With
Chronic Kidney Disease (Ckd) - The Averroes Trial
2.3 TRV120027, a Novel beta-Arrestin Biased Ligand at the Angiotensin II type I Receptor, Unloads the Heart
and Maintains Renal Function when added to Furosemide in Experimental Heart Failure
2.4 Cardiorenal Actions of the Designer Natriuretic Peptide, CD-NP, in a Severe Heart Failure model Treated
with Furosemide.
2.5 Effect of Specific ADRB1/ADRB2/AGT Genotype Combinations on the Association Between Survival and
Carvedilol Treatment in Chronic Heart Failure
2.6 Double-blind, Randomized Comparison Between Zofenopril and Ramipril in Patients with LV Dysfunction
Treated with ASA - the SMILE IV Study
2.7 Cost-effectiveness of NT-proBNP-guided Therapy in Heart Failure; Results From the TIME-CHF Study
2.8 Acetylsalicylic Acid Inhibits Thromboxane A2 production and Thromboxane A2-dependent Platelet
Function Equally well in Diabetic and Non-Diabetic Subjects
2.9 Rho-Kinase Activity in Circulating Neutrophils of Patients with Vasospastic Angina - Non-Invasive Method
for Diagnosis and Disease Activity Assessment
2.10 Intravenous Nicorandil Improves Symptoms and Left Ventricular Diastolic Function Immediately in
Patients With Acute Heart Failure - a Randomized, Controlled Trial.
2.11 LDL-Cholesterol - The Lower, the Better - is it True For Plaque Regression? Statin Alone Versus
Combination of Ezetimibe and Statin
2.12 In Vitro and Vivo Gene Targeting with Adenoviral Vector Conjugated Magnetic Nanobeads for Cardiac
Regeneration
2.13 SERCA2a Gene Transfer Prevents Coronary Spasm
2.14 The Prohormone of B-type Natriuretic Peptide, proBNP1-108, is Secreted by the Failing and Non-failing
Human Heart
2.15 Plasma Renin Activity and Angiotensinogen M235T Polymorphism are Determinants of Aldosterone
Escape in Patients with Systolic Heart Failure
2.16 Three-year Clinical Outcomes of the OLIVUS (Impact of OLmesartan on Progression of Coronary
Atherosclerosis; Evaluation by IntraVascular UltraSound) Trial
2.17 Benefits of Statin Therapy on Long Term Prognosis in Coronary Artery Disease
2.18 Risk of Cardiovascular Outcomes after Low-Dose Acetylsalicylic Acid Discontinuation - a UK Primary
Care Study
2.19 Evaluation of Safety and Efficacy of Inocitol Hexanicotinic Acid (IHN) Versus Nicotinic Acid in the
Treatment of Dyslipidemia
2.20 Angiotensin-Converting Enzyme Inhibitor Therapy in Non-Obstructive Coronary Artery Disease
3 Appendix
3.1 Abbreviations
3.2 Disclaimer
1.1 List of Tables
Table 1: Olmesartan Therapy Long Term Clinical Outcomes
Table 2: The Risk of MI/Coronary Death and The Risk of IS/TIA Discontinuation of Low-Dose ASA
Table 3: HDL Change from Baseline
1.2 List of Figures
Figure 1: Genotype Combinations on the Association Between Survival and Carvedilol Treatment in Chronic
Heart Failure (CHF)
Figure 2: Cost-Effectiveness of NT-proBNP-Guided Therapy in Heart Failure
Ordering:
Order Online - http://www.researchandmarkets.com/reports/1934395/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
European Society of Cardiology Congress 2011 - Post-Conference Review and
Analysis
Web Address:
http://www.researchandmarkets.com/reports/1934395/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Enterprisewide:
USD 3000
Electronic (PDF) Site License:
USD 2000
Electronic (PDF) Single User:
USD 1000
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World